Prenatal Detection of Congenital Renal Malformations by Fetal Ultrasonographic Examination: An Analysis of 709,030 Births in 12 European Countries
Introduction
Major birth defects are diagnosed in 2–7 percent of infants and fetuses. Malformations are the single leading cause of infant mortality and account for 1/3 of all pediatric admissions. Optimal treatment and prevention of congenital malformation are essential tasks of perinatal medicine [18], [19].
The idea to use ultrasound (US) as a routine examination in neonates was formed in the late 1970s. First valid studies were undertaken thereafter [14], [28]. Today ultrasound investigations in pregnancy are a part of routine antenatal care in most countries of the western hemisphere. In Europe, the scanning policies vary from none to three routine prenatal US examinations. A recommendation for at least 2 ultrasound scans for the identification of malformations has existed since the beginning of the 1990s [22]. A routine ultrasound scan for major malformations in the mid-trimester of pregnancy was performed in 10 out of 12 participating European countries. The policy for termination of pregnancies (TOP) relies, besides amniocentesis, mainly on prenatal diagnosis (PD) by ultrasound examinations. Prenatally detected renal malformations account for approximately 20–30% of all prenatal detected congenital anomalies [19]. Most diagnoses of this heterogeneous group are detectable by prenatal ultrasound examinations in the second trimester of pregnancy.
The aims of the EUROSCAN study (a multicenter concerted action) were to evaluate the prenatal detection rate of major congenital malformations across Europe, to compare different scanning policies including TOPs, and draw conclusions for an improvement in prenatal care. This report shows the results for renal malformations. Other parts of the concerted action have been published [in ref. 25].
Section snippets
Methods
Twenty congenital malformations registries from 12 European countries provided data (Table 1). Sixteen registries collaborate in the EUROCAT program, applying the same epidemiological methodologies. These methods were also used by the remaining four registries [11]. The study period was from July 1st 1996 to December 31st 1998, but not all registries were able to cover the whole time period. The different scanning policies are described in Table 1. Except two (Styria and Leipzig), all
General descriptive data
Table 1 indicates the distribution of cases by registries, as well as the policies of the different countries concerning terminations of pregnancies (TOP), reflecting the situation in the European Union (EU). Twenty registries reported a total of 709,030 births with 8,126 (1.15/1000) cases of major congenital anomalies, 1,130 (0.16%) of which with renal malformations (Table 1).
The registries, number of cases, the prevalence rates, the prenatally diagnosed cases, and the number of cases
Discussion
Renal malformations are detected in ca. 0.2–2% of all newborns [10], [20], [24], [28]. Prenatal diagnosis of renal malformations was reported in 0.5% of newborns in the late 1990s. Half of these need surgical intervention within the next year [8].
Normal and abnormal development of the kidneys as the patho-physiological base of congenital renal malformations and prenatal ultrasound diagnoses has been described extensively e.g., by Cuckow et al. [7] and Zhou et al. [29]. Only renal diagnoses
Conclusions
The important criteria for screening programs—the existence of preventive or therapeutic interventions, aggravation of the prognosis due to the lack of adequate measures, and health benefit from therapy—are completely fulfilled by US screening examinations in newborns. Early diagnosis of a renal malformation can lead to a more efficient treatment and better outcome by avoiding greater harm, for example recurrent infections. If known before birth even the course of pregnancy and needs of the
Acknowledgements
The EUROSCAN study was funded by the European Union BIOMED II program, Contract no. BMH4CT960539.
References (29)
- et al.
Prenatal diagnosis of fetal multicystic dysplastic kidney with two-dimensional and three-dimensional ultrasound
Ultrasound Med. Biol.
(2002) - et al.
A randomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses
Am. J. Obstet. Gynecol.
(1994) - et al.
The performance of routine ultrasonographic screening of pregnancies in the Eurofetus study
Am. J. Obstet. Gynecol.
(1999) - et al.
Postnatal ultrasound screening of urinary malformations
Urology
(1992) Debate about ultrasound screening policies
Fetal Diagn. Ther.
(1998)- et al.
Effectiveness of routine ultrasonography in detecting fetal structural abnormalities in a low risk population
BMJ
(1991) Ultrasound screening for fetal abnormalities
Prenat. Diagn.
(1995)- et al.
Urinary tract abnormalities (UTA) and associated malformations: data of the Emilia-Romagna Registry. IMER Group. Emilia-Romagna registry on congenital malformations
Eur. J. Epidemiol.
(1996) - et al.
Normal and abnormal development of the urogenital tract
Prenat. Diagn.
(2001) - et al.
A 16 year audit of antenatal ultrasound detection of renal disease
Br. J. Radiol.
(1998)